The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation.
about
Structure of the MLT gene and molecular characterization of the genomic breakpoint junctions in the t(11;18)(q21;q21) of marginal zone B-cell lymphomas of MALT typeMALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expressionFAS (CD95) mutations are rare in gastric MALT lymphoma but occur more frequently in primary gastric diffuse large B-cell lymphomaMolecular diagnostic approach to non-Hodgkin's lymphoma.Pathology of lymphoma progression.The new World Health Organization classification of lymphomas: the past, the present and the future.MALT1 and BCL10 aberrations in MALT lymphomas and their effect on the expression of BCL10 in the tumour cells.Marginal zone cell lymphoma--an update on recent advances.T(11;18)(q21;q21)-positive gastrointestinal MALT lymphomas are heterogeneous with respect to the V(H) gene mutation status.Molecular biology of gastric MALT lymphoma: application in clinical management.Chromosomal translocation t(11;18)(q21;q21) in gastrointestinal mucosa associated lymphoid tissue lymphomaDistinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas.API2-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma: multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimensMucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways.API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomasPrimary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular features.Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?Gastrointestinal lymphoma: where morphology meets molecular biology.Apoptosis-based therapies and drug targets.Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein.Management of marginal zone lymphomas.Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management.Gastrointestinal B-cell lymphomas: From understanding B-cell physiology to classification and molecular pathologyComparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare databaseThe inhibitors of apoptosis (IAPs) as cancer targets.Mucosa-associated lymphoid tissue lymphoma: molecular pathogenesis and clinicopathological significance.Therapy of gastric mucosa associated lymphoid tissue lymphoma.Cutting-edge apoptosis-based therapeutics: a panacea for cancer?IAP-targeted therapies for cancer.High-grade hepatic mucosa-associated lymphoid tissue (MALT) lymphoma probably transformed from the low-grade gastric MALT lymphoma.Primary cutaneous marginal zone B-cell lymphomas: are they different from other extranodal marginal zone B-cell lymphomas?Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development.Geographic variation and environmental conditions as cofactors in Chlamydia psittaci association with ocular adnexal lymphomas: a comparison between Italian and African samples.From MALT lymphoma to the CBM signalosome: three decades of discovery.Molecular pathogenesis and histologic and clinical features of extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue type.Molecular diagnostics of non-Hodgkin lymphoma.Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.The B-cell-activating factor signalling pathway is associated with Helicobacter pylori independence in gastric mucosa-associated lymphoid tissue lymphoma without t(11;18)(q21;q21).The role of miRNAs and epigenetic mechanisms in primary gastric mucosa-associated lymphoid tissue lymphoma.
P2860
Q28143157-9B9D9BBD-FF3A-41F8-B778-5465A1D3BA50Q28305065-D62A1D8D-78D7-4DC1-87F7-21A7D4468F72Q28767089-43CCFD78-163B-4141-9E58-CCB9B5D9DED5Q33936373-09FAE398-D9DB-444D-8034-C0E4A10BDBBFQ34229327-677FA849-64A1-4F31-8BEF-D1C75378A0EDQ34469138-8917C979-7077-4678-9930-2D8FE49CBD4FQ34474895-4D853205-DAA3-41C5-B925-73E833D39A8EQ34600740-02E10F53-D8C6-46D7-8A02-1A88BB6D959AQ34612166-B3F5BB2A-571E-4508-9FFE-D4D10BAF91B0Q35022121-14CF4CB7-C9E3-48F4-98EA-64E9C5915644Q35033500-5D7FEAC1-9F9A-4546-B8CE-5F5FA9AC538AQ35595610-B79E975C-4BE3-48F2-8BF0-24991589551DQ35746352-FC81DDF1-0E3B-4CAE-8288-827EE8CA44AFQ35747503-FC54492C-74AB-4F28-903B-FAAA3D6AC6DCQ35749277-B67F557C-3FB4-4DB7-B8F2-FFB5099444AFQ35761034-C7CE0365-6203-4F87-BC48-7587EFFE87F9Q35788892-F7368F87-5BF4-4AF5-9C56-C6FD35988A0EQ35905166-1A54E1CB-2EA5-4881-8B3A-B7985C4992B8Q36005932-F5B8C5E1-0780-490D-AE75-C7CE0E1D0D9CQ36017772-F45F4105-9E15-412A-A3C7-8AC653DB5B9AQ36435203-EFEC2373-15EB-4AE5-9F54-D6398D78D8D1Q36449513-DEF72E0C-83F0-4573-8727-EE4107113830Q36477917-84E6F9D5-CAF3-42A6-90C2-F82E9F0C8C29Q36637130-45AD33F2-33F3-4C29-B994-D8CC511B0ADFQ36777008-FBD59C9F-86E0-4548-B441-5EF0C1B52399Q36851057-0ED561AE-12C4-4C08-A7D9-BB768CD3A2ABQ36870112-83264611-585C-4A13-902E-3E60C2CBE897Q36894785-6F03B5C1-5922-4D70-91FB-DA9F932FADA9Q36951942-A09CD2D5-D2B2-4956-BE83-4D16F5DDA4A4Q37302745-757E81BF-2039-4ABB-89A7-E96925040791Q37474457-B2DD5B6D-C9E9-4E35-9AEB-D291CE71F0E3Q37514390-F2C6A03C-0DAB-4E3A-A6D3-E81AC8C06E86Q37741791-68D43534-E468-453B-954C-482F68934F9EQ37854356-F40E7C0D-AB91-4463-9C60-B5492203A9FEQ37900457-EEE79BC1-D219-46A0-B9EF-A65AC6DC578CQ37944372-E4BD771A-0A3C-4B2C-B62A-2EE5588BE9D0Q38089227-EA4BE272-A654-4DBA-91E9-0FD4536D9CABQ38182355-8D3FD9AC-B2F9-44F9-87DE-EF360F689702Q38729695-7C8DBAA7-C2D6-4727-B561-A1E2D41FF0B3Q38808597-4EBA2014-98B0-4919-A713-17AE4DED33B3
P2860
The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
The product of the t(11;18), a ...... hout large cell proliferation.
@en
The product of the t(11;18), a ...... hout large cell proliferation.
@nl
type
label
The product of the t(11;18), a ...... hout large cell proliferation.
@en
The product of the t(11;18), a ...... hout large cell proliferation.
@nl
prefLabel
The product of the t(11;18), a ...... hout large cell proliferation.
@en
The product of the t(11;18), a ...... hout large cell proliferation.
@nl
P2093
P2860
P1476
The product of the t(11;18), a ...... hout large cell proliferation.
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)65012-2
P407
P577
2000-04-01T00:00:00Z